BamSEC and AlphaSense Join Forces
Learn More

Palisade Bio Inc. – Underwriting Agreements

NASDAQ: PALI    
Share price (5/22/26): $1.95    
Market cap (5/22/26): $338 million

Underwriting Agreements Filter

EX-1
from SCHEDULE 13G/A 1 page Joint Filing Agreement
12/34/56
EX-1
from SCHEDULE 13G/A Underwriting agreement
12/34/56
EX-1
from SCHEDULE 13G 1 page Joint Filing Agreement
12/34/56
EX-1
from SCHEDULE 13G Underwriting agreement
12/34/56
EX-1.1
from S-1 40 pages [___] Shares of Common Stock and [___] Pre-Funded Warrants to Purchase Up to [ ] Shares of Common Stock of Palisade Bio, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1 38 pages [ ] Shares of Common Stock and [___] Pre-Funded Warrants to Purchase Up to [ ] Shares of Common Stock of Palisade Bio, Inc. Underwriting Agreement
12/34/56
EX-1.01
from 8-K 36 pages 158,000 Shares of Common Stock, 3,120,688 Pre-Funded Warrants to Purchase Up to 3,120,688 Shares of Common Stock and 3,278,688 Common Warrants to Purchase Up to 3,278,688 Shares of Common Stock of Palisade Bio, Inc. Underwriting Agreement
12/34/56
EX-1.01
from S-1/A 42 pages [ ] Shares of Common Stock, [ ] Pre-Funded Warrants to Purchase Up to [ ] Shares of Common Stock and [ ] Common Warrants to Purchase Up to [ ] Shares of Common Stock of Palisade Bio, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 42 pages [ ] Shares of Common Stock and [ ] Warrants to Purchase Up to [ ] Shares of Common Stock of Palisade Bio, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13G/A ~5 pages Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.1
from 8-K 45 pages 42,160,000 Shares of Common Stock, 1,460 Shares of Series B Convertible Preferred Stock (Convertible Into 5,840,000 Shares of Common Stock) 48,000,000 Series 1 Warrants (Exercisable for 48,000,000 Shares of Common Stock) and 48,000,000 Series 2 Warrants (Exercisable for 48,000,000 Shares of Common Stock) of Palisade Bio, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 45 pages Shares of Common Stock, Shares of Series B Convertible Preferred Stock (Convertible Into Shares of Common Stock) Series 1 Warrants (Exercisable for Shares of Common Stock) and Series 2 Warrants (Exercisable for Shares of Common Stock) of Palisade Bio, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 45 pages Shares of Common Stock, Shares of Series B Convertible Preferred Stock (Convertible Into Shares of Common Stock) Series 1 Warrants (Exercisable for Shares of Common Stock) and Series 2 Warrants (Exercisable for Shares of Common Stock) of Palisade Bio, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 44 pages Shares of Common Stock, Shares of Series B Convertible Preferred Stock (Convertible Into Shares of Common Stock) and Warrants (Exercisable for Shares of Common Stock) of Palisade Bio, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1
12/34/56
EX-1.01
from S-1/A 42 pages Shares of Common Stock, Series M Warrants (Exercisable for Shares), Series N Warrants (Exercisable for Shares) and Series O Prefunded Warrants (Exercisable for Shares) of Neuralstem, Inc. Underwriting Agreement
12/34/56
EX-1.01
from 8-K 42 pages 3,000,000 Shares of Common Stock and Warrants to Purchase 2,250,000 Shares of Common Stock Neuralstem, Inc. Underwriting Agreement
12/34/56
EX-1.01
from 8-K 36 pages 20,000,000 Shares of Common Stock and Warrants to Purchase 20,000,000 Shares of Common Stock Neuralstem, Inc. Underwriting Agreement
12/34/56
EX-1.01
from 8-K 3 pages Underwriting agreement
12/34/56
EX-1.01
from 8-K 3 pages Underwriting agreement
12/34/56